For research use only. Not for therapeutic Use.
(R)-Dapoxetine-d3 Hydrochloride is a deuterium-labeled analog of dapoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI). It acts by inhibiting the serotonin transporter, increasing serotonin’s action at the synaptic cleft, which delays ejaculation and thus is used in the treatment of premature ejaculation. Its isotopic labeling makes it valuable in pharmacokinetic studies, enhancing the understanding of dapoxetine’s metabolism and distribution in biological systems. This compound is crucial in pharmaceutical research, particularly in studying drug interactions and optimizing therapeutic regimens for sexual health applications.
Catalog Number | R064177 |
CAS Number | NA |
Synonyms | (αR)-N,N-Dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-benzenemethanamine-d3 Hydrochloride; |
Molecular Formula | C₂₁H₂₁D₃ClNO |
Purity | ≥95% |
Storage | Store at +4°C |
IUPAC Name | N-methyl-3-naphthalen-1-yloxy-1-phenyl-N-(trideuteriomethyl)propan-1-amine;hydrochloride |
InChI | InChI=1S/C21H23NO.ClH/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21;/h3-14,20H,15-16H2,1-2H3;1H/i1D3; |
InChIKey | IHWDIQRWYNMKFM-NIIDSAIPSA-N |
SMILES | [2H]C([2H])([2H])N(C)C(CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3.Cl |